Mirae Asset Global ETFs Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Sell
129,504
-5,810
-4% -$52.3K ﹤0.01% 1376
2025
Q1
$1.02M Buy
135,314
+8,517
+7% +$64.1K ﹤0.01% 1488
2024
Q4
$954K Sell
126,797
-929
-0.7% -$6.99K ﹤0.01% 1571
2024
Q3
$971K Buy
127,726
+14,199
+13% +$108K ﹤0.01% 1555
2024
Q2
$700K Buy
+113,527
New +$700K ﹤0.01% 1650